25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

TMDX (Transmedics) Stock Analysis
Buy, Hold or Sell?

Let's analyze Transmedics together

I guess you are interested in TransMedics Group Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • ๐Ÿ“Š Fundamental Analysis (FA) โ€“ Transmedicsโ€™s Financial Insights
  • ๐Ÿ“ˆ Technical Analysis (TA) โ€“ Transmedicsโ€™s Price Targets

I'm going to help you getting a better view of TransMedics Group Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about TransMedics Group Inc

I send you an email if I find something interesting about TransMedics Group Inc.

1. Quick Overview

1.1. Quick analysis of Transmedics (30 sec.)










1.2. What can you expect buying and holding a share of Transmedics? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$6.67
Expected worth in 1 year
$8.75
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
$2.07
Return On Investment
1.6%

For what price can you sell your share?

Current Price per Share
$131.45
Expected price per share
$95.90 - $169.29
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Transmedics (5 min.)




Live pricePrice per Share (EOD)
$131.45
Intrinsic Value Per Share
$-31.49 - $-36.51
Total Value Per Share
$-24.82 - $-29.84

2.2. Growth of Transmedics (5 min.)




Is Transmedics growing?

Current yearPrevious yearGrowGrow %
How rich?$266.3m$142m$81.5m36.5%

How much money is Transmedics making?

Current yearPrevious yearGrowGrow %
Making money$12.2m-$2.5m$14.7m120.8%
Net Profit Margin9.5%-5.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Transmedics (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#86 / 298

Most Revenue
#63 / 298

Most Profit
#52 / 298
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Transmedics?

Welcome investor! Transmedics's management wants to use your money to grow the business. In return you get a share of Transmedics.

First you should know what it really means to hold a share of Transmedics. And how you can make/lose money.

Speculation

The Price per Share of Transmedics is $131.45. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Transmedics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Transmedics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $6.67. Based on the TTM, the Book Value Change Per Share is $0.52 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.27 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Transmedics.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.640.5%0.330.2%-0.08-0.1%0.010.0%-0.10-0.1%-0.14-0.1%
Usd Book Value Change Per Share0.180.1%0.520.4%-0.27-0.2%0.410.3%0.260.2%0.200.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.180.1%0.520.4%-0.27-0.2%0.410.3%0.260.2%0.200.2%
Usd Price Per Share67.28-109.31-72.90-78.29-57.25-37.24-
Price to Earnings Ratio26.14-136.84--126.99--29.33--27.30--18.97-
Price-to-Total Gains Ratio374.59-245.58-63.32--226.40--178.76--158.00-
Price to Book Ratio10.08-18.59-17.49-16.43-13.96-9.89-
Price-to-Total Gains Ratio374.59-245.58-63.32--226.40--178.76--158.00-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share131.45
Number of shares7
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.520.26
Usd Total Gains Per Share0.520.26
Gains per Quarter (7 shares)3.631.85
Gains per Year (7 shares)14.517.41
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1015507-3
2029200154
30443502211
40585003018
50736503725
60878004432
701029505239
8011611005946
9013112506753
10014514007460

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%6.06.00.050.0%6.014.00.030.0%6.027.00.018.2%6.027.00.018.2%
Book Value Change Per Share4.00.00.0100.0%8.04.00.066.7%9.011.00.045.0%11.018.04.033.3%11.018.04.033.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.033.00.0%0.00.033.00.0%
Total Gains per Share4.00.00.0100.0%8.04.00.066.7%9.011.00.045.0%11.018.04.033.3%11.018.04.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of TransMedics Group Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1800.518-65%-0.274+252%0.408-56%0.265-32%0.202-11%
Book Value Per Share--6.6726.107+9%4.161+60%4.947+35%4.032+65%2.681+149%
Current Ratio--9.0998.743+4%12.662-28%10.143-10%9.798-7%7.267+25%
Debt To Asset Ratio--0.6820.720-5%0.798-15%0.634+8%0.533+28%0.538+27%
Debt To Equity Ratio--2.1452.600-17%3.972-46%2.419-11%1.709+26%1.916+12%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--2424367685.3603711743623.668-35%2367226424.293+2%2647009735.320-8%1959017768.592+24%1756437701.077+38%
Eps--0.6430.325+98%-0.078+112%0.013+4915%-0.103+116%-0.141+122%
Ev To Ebitda Ratio--16.70956.050-70%74.975-78%-965.928+5881%-592.343+3645%-497.784+3079%
Ev To Sales Ratio--4.2237.933-47%8.504-50%10.587-60%19.858-79%21.409-80%
Free Cash Flow Per Share---0.749-0.420-44%-1.689+126%-0.819+9%-0.602-20%-0.446-40%
Free Cash Flow To Equity Per Share---0.673-0.262-61%1.263-153%0.640-205%0.387-274%0.257-362%
Gross Profit Margin--1.0000.986+1%1.264-21%1.318-24%1.196-16%1.131-12%
Intrinsic Value_10Y_max---36.507----------
Intrinsic Value_10Y_min---31.494----------
Intrinsic Value_1Y_max---3.335----------
Intrinsic Value_1Y_min---3.276----------
Intrinsic Value_3Y_max---10.267----------
Intrinsic Value_3Y_min---9.797----------
Intrinsic Value_5Y_max---17.496----------
Intrinsic Value_5Y_min---16.218----------
Market Cap4447453010.000+40%2685446685.3603949591373.668-32%2488918424.293+8%2740065901.987-2%1991614168.592+35%1292986994.722+108%
Net Profit Margin--0.1790.095+88%-0.057+132%-0.081+145%-0.592+431%-1.111+721%
Operating Margin--0.2100.111+90%-0.026+112%-0.055+126%-0.518+347%-1.013+582%
Operating Ratio--0.8090.898-10%1.071-24%1.069-24%1.532-47%2.007-60%
Pb Ratio19.702+49%10.08418.591-46%17.489-42%16.432-39%13.963-28%9.886+2%
Pe Ratio51.074+49%26.141136.841-81%-126.994+586%-29.328+212%-27.297+204%-18.968+173%
Price Per Share131.450+49%67.280109.313-38%72.900-8%78.291-14%57.248+18%37.236+81%
Price To Free Cash Flow Ratio-43.879-95%-22.459178.491-113%-33.937+51%32.849-168%9.073-348%2.775-909%
Price To Total Gains Ratio731.858+49%374.587245.584+53%63.317+492%-226.400+160%-178.756+148%-158.004+142%
Quick Ratio--8.1327.638+6%11.638-30%9.186-11%11.140-27%8.331-2%
Return On Assets--0.0310.015+102%-0.004+113%-0.009+131%-0.032+206%-0.055+280%
Return On Equity--0.0960.053+83%-0.026+126%-0.017+118%-0.056+158%-0.166+272%
Total Gains Per Share--0.1800.518-65%-0.274+252%0.408-56%0.265-32%0.202-11%
Usd Book Value--266308000.000223681250.000+19%142086500.000+87%173487250.000+54%140100950.000+90%92939000.000+187%
Usd Book Value Change Per Share--0.1800.518-65%-0.274+252%0.408-56%0.265-32%0.202-11%
Usd Book Value Per Share--6.6726.107+9%4.161+60%4.947+35%4.032+65%2.681+149%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--2424367685.3603711743623.668-35%2367226424.293+2%2647009735.320-8%1959017768.592+24%1756437701.077+38%
Usd Eps--0.6430.325+98%-0.078+112%0.013+4915%-0.103+116%-0.141+122%
Usd Free Cash Flow---29893000.000-15806750.000-47%-57526500.000+92%-28357166.667-5%-20764750.000-31%-15332181.818-49%
Usd Free Cash Flow Per Share---0.749-0.420-44%-1.689+126%-0.819+9%-0.602-20%-0.446-40%
Usd Free Cash Flow To Equity Per Share---0.673-0.262-61%1.263-153%0.640-205%0.387-274%0.257-362%
Usd Market Cap4447453010.000+40%2685446685.3603949591373.668-32%2488918424.293+8%2740065901.987-2%1991614168.592+35%1292986994.722+108%
Usd Price Per Share131.450+49%67.280109.313-38%72.900-8%78.291-14%57.248+18%37.236+81%
Usd Profit--25682000.00012237250.000+110%-2548750.000+110%870750.000+2849%-3211200.000+113%-4583681.818+118%
Usd Revenue--143537000.000122056750.000+18%74229750.000+93%75356583.333+90%48426500.000+196%30931575.758+364%
Usd Total Gains Per Share--0.1800.518-65%-0.274+252%0.408-56%0.265-32%0.202-11%
 EOD+5 -3MRQTTM+22 -16YOY+28 -103Y+20 -185Y+21 -1710Y+21 -17

3.3 Fundamental Score

Let's check the fundamental score of TransMedics Group Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1551.074
Price to Book Ratio (EOD)Between0-119.702
Net Profit Margin (MRQ)Greater than00.179
Operating Margin (MRQ)Greater than00.210
Quick Ratio (MRQ)Greater than18.132
Current Ratio (MRQ)Greater than19.099
Debt to Asset Ratio (MRQ)Less than10.682
Debt to Equity Ratio (MRQ)Less than12.145
Return on Equity (MRQ)Greater than0.150.096
Return on Assets (MRQ)Greater than0.050.031
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of TransMedics Group Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.838
Ma 20Greater thanMa 50133.465
Ma 50Greater thanMa 100117.002
Ma 100Greater thanMa 20094.279
OpenGreater thanClose130.790
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Fundamental data was last updated by Penke on 2025-06-20 17:41:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitย Transmedics earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareย Transmedics to theย Medical Devices industry mean.
  • A Net Profit Margin of 17.9%ย means thatย $0.18 for each $1ย in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of TransMedics Group Inc:

  • The MRQ is 17.9%. The company is making a huge profit. +2
  • The TTM is 9.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ17.9%TTM9.5%+8.4%
TTM9.5%YOY-5.7%+15.2%
TTM9.5%5Y-59.2%+68.7%
5Y-59.2%10Y-111.1%+51.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ17.9%-6.0%+23.9%
TTM9.5%-10.2%+19.7%
YOY-5.7%-12.9%+7.2%
3Y-8.1%-12.6%+4.5%
5Y-59.2%-10.4%-48.8%
10Y-111.1%-9.0%-102.1%
4.3.1.2. Return on Assets

Shows howย efficientย Transmedics is using its assets to generate profit.

  • Above 5% is considered healthyย but always compareย Transmedics to theย Medical Devices industry mean.
  • 3.1% Return on Assets means thatย Transmedics generatedย $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of TransMedics Group Inc:

  • The MRQ is 3.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.1%TTM1.5%+1.6%
TTM1.5%YOY-0.4%+1.9%
TTM1.5%5Y-3.2%+4.8%
5Y-3.2%10Y-5.5%+2.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1%-2.1%+5.2%
TTM1.5%-2.3%+3.8%
YOY-0.4%-3.4%+3.0%
3Y-0.9%-2.9%+2.0%
5Y-3.2%-2.6%-0.6%
10Y-5.5%-2.4%-3.1%
4.3.1.3. Return on Equity

Shows how efficient Transmedics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareย Transmedics to theย Medical Devices industry mean.
  • 9.6% Return on Equity means Transmedics generated $0.10ย for eachย $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of TransMedics Group Inc:

  • The MRQ is 9.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ9.6%TTM5.3%+4.4%
TTM5.3%YOY-2.6%+7.8%
TTM5.3%5Y-5.6%+10.9%
5Y-5.6%10Y-16.6%+11.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ9.6%-1.8%+11.4%
TTM5.3%-2.6%+7.9%
YOY-2.6%-3.6%+1.0%
3Y-1.7%-3.8%+2.1%
5Y-5.6%-4.0%-1.6%
10Y-16.6%-5.4%-11.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of TransMedics Group Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measuresย how efficient Transmedics is operatingย .

  • Measures how much profit Transmedics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareย Transmedics to theย Medical Devices industry mean.
  • An Operating Margin of 21.0%ย means the company generated $0.21 ย for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of TransMedics Group Inc:

  • The MRQ is 21.0%. The company is operating efficient. +1
  • The TTM is 11.1%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ21.0%TTM11.1%+9.9%
TTM11.1%YOY-2.6%+13.6%
TTM11.1%5Y-51.8%+62.9%
5Y-51.8%10Y-101.3%+49.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ21.0%-9.6%+30.6%
TTM11.1%-13.8%+24.9%
YOY-2.6%-9.8%+7.2%
3Y-5.5%-9.6%+4.1%
5Y-51.8%-9.8%-42.0%
10Y-101.3%-11.2%-90.1%
4.3.2.2. Operating Ratio

Measures how efficient Transmedics is keepingย operating costsย low.

  • Below 1 is considered healthy (always compare toย Medical Devices industry mean).
  • An Operation Ratio of 0.81 means that the operating costs are $0.81 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of TransMedics Group Inc:

  • The MRQ is 0.809. The company is less efficient in keeping operating costs low.
  • The TTM is 0.898. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.809TTM0.898-0.089
TTM0.898YOY1.071-0.173
TTM0.8985Y1.532-0.634
5Y1.53210Y2.007-0.474
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8091.370-0.561
TTM0.8981.347-0.449
YOY1.0711.292-0.221
3Y1.0691.335-0.266
5Y1.5321.355+0.177
10Y2.0071.322+0.685
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of TransMedics Group Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Transmedics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toย Medical Devices industry mean).
  • A Current Ratio of 9.10ย means the company has $9.10 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of TransMedics Group Inc:

  • The MRQ is 9.099. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.743. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.099TTM8.743+0.356
TTM8.743YOY12.662-3.918
TTM8.7435Y9.798-1.055
5Y9.79810Y7.267+2.531
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ9.0992.536+6.563
TTM8.7432.708+6.035
YOY12.6622.691+9.971
3Y10.1432.963+7.180
5Y9.7983.576+6.222
10Y7.2673.302+3.965
4.4.3.2. Quick Ratio

Measures if Transmedics is able to pay off Short-term Debt but only usingย theย most liquid assets.

  • Above 1 is considered healthy butย always compareย Transmedics to theย Medical Devices industry mean.
  • A Quick Ratio of 8.13ย means the company can pay off $8.13 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of TransMedics Group Inc:

  • The MRQ is 8.132. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.638. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.132TTM7.638+0.494
TTM7.638YOY11.638-4.000
TTM7.6385Y11.140-3.503
5Y11.14010Y8.331+2.809
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ8.1321.075+7.057
TTM7.6381.412+6.226
YOY11.6381.632+10.006
3Y9.1861.798+7.388
5Y11.1402.142+8.998
10Y8.3312.375+5.956
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of TransMedics Group Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %ย of Transmedicsย assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareย Transmedics to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.68ย means that Transmedics assets areย financed with 68.2% credit (debt) and the remaining percentage (100% - 68.2%)ย is financed by its owners/shareholders.ย 

Let's take a look of the Debt to Asset Ratio trends of TransMedics Group Inc:

  • The MRQ is 0.682. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.720. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.682TTM0.720-0.038
TTM0.720YOY0.798-0.078
TTM0.7205Y0.533+0.188
5Y0.53310Y0.538-0.006
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6820.397+0.285
TTM0.7200.410+0.310
YOY0.7980.391+0.407
3Y0.6340.388+0.246
5Y0.5330.414+0.119
10Y0.5380.455+0.083
4.5.4.2. Debt to Equity Ratio

Measures ifย Transmedics is able toย pay off its debts by usingย shareholders equity.

  • Below 2 is considered healthy butย always compareย Transmedics to theย Medical Devices industry mean.
  • A Debt to Equity ratio of 214.5% means that company has $2.14 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of TransMedics Group Inc:

  • The MRQ is 2.145. The company is just not able to pay all its debts with equity.
  • The TTM is 2.600. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.145TTM2.600-0.455
TTM2.600YOY3.972-1.372
TTM2.6005Y1.709+0.891
5Y1.70910Y1.916-0.207
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1450.545+1.600
TTM2.6000.619+1.981
YOY3.9720.589+3.383
3Y2.4190.638+1.781
5Y1.7090.644+1.065
10Y1.9160.747+1.169
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measuresย how much money you payย for each share forย every $1 in earnings Transmedics generates.

  • Above 15 is considered overpriced butย always compareย Transmedics to theย Medical Devices industry mean.
  • A PE ratio of 26.14 means the investor is paying $26.14ย for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of TransMedics Group Inc:

  • The EOD is 51.074. Based on the earnings, the company is expensive. -2
  • The MRQ is 26.141. Based on the earnings, the company is overpriced. -1
  • The TTM is 136.841. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD51.074MRQ26.141+24.933
MRQ26.141TTM136.841-110.700
TTM136.841YOY-126.994+263.835
TTM136.8415Y-27.297+164.138
5Y-27.29710Y-18.968-8.329
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD51.074-1.311+52.385
MRQ26.141-1.454+27.595
TTM136.841-1.183+138.024
YOY-126.994-1.875-125.119
3Y-29.328-1.328-28.000
5Y-27.297-1.869-25.428
10Y-18.968-1.606-17.362
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of TransMedics Group Inc:

  • The EOD is -43.879. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -22.459. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 178.491. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-43.879MRQ-22.459-21.421
MRQ-22.459TTM178.491-200.950
TTM178.491YOY-33.937+212.428
TTM178.4915Y9.073+169.418
5Y9.07310Y2.775+6.298
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-43.879-2.379-41.500
MRQ-22.459-3.094-19.365
TTM178.491-1.554+180.045
YOY-33.937-3.669-30.268
3Y32.849-3.423+36.272
5Y9.073-3.323+12.396
10Y2.775-3.442+6.217
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofย Transmedics is to cheap or to expensiveย compared to its book value.

  • At or below 1 is considered healthyย (always compare to Medical Devices industry mean).
  • A PB ratio of 10.08 means the investor is paying $10.08ย for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of TransMedics Group Inc:

  • The EOD is 19.702. Based on the equity, the company is expensive. -2
  • The MRQ is 10.084. Based on the equity, the company is expensive. -2
  • The TTM is 18.591. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD19.702MRQ10.084+9.618
MRQ10.084TTM18.591-8.507
TTM18.591YOY17.489+1.102
TTM18.5915Y13.963+4.629
5Y13.96310Y9.886+4.077
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD19.7021.945+17.757
MRQ10.0841.989+8.095
TTM18.5912.230+16.361
YOY17.4892.682+14.807
3Y16.4322.718+13.714
5Y13.9633.884+10.079
10Y9.8864.251+5.635
4.6.2. Total Gains per Share

2.4. Latest News of TransMedics Group Inc

Does TransMedics Group Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from TransMedics Group Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-28
15:10
10 Under-the-Radar Healthcare Stocks With Incredible Growth PotentialRead
2025-06-28
15:10
10 Under-the-Radar Healthcare Stocks With Incredible Growth PotentialRead
2025-06-26
19:37
3 Stocks That May Be Undervalued In June 2025Read
2025-06-24
21:09
Oppenheimer Raises TransMedics (TMDX) PT to $150 Following Key OrganOx Metra Label UpdateRead
2025-06-20
19:38
Victory Capital Holdings And 2 Other Stocks That May Be Priced Below Their Estimated ValueRead
2025-06-10
16:39
Kuehn Law Encourages Investors of TransMedics Group, Inc. to Contact Law FirmRead
2025-06-09
15:36
TransMedics Group, Inc. (TMDX): A Bull Case TheoryRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of TransMedics Group Inc.

4.8.1. Institutions holding TransMedics Group Inc

Institutions are holding 121.558% of the shares of TransMedics Group Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc15.51150.00745248129199420.3814
2025-03-31FMR Inc14.77220.0215499800999056224.718
2025-03-31Vanguard Group Inc10.56630.00443574996-60923-1.6756
2025-03-31UBS Asset Mgmt Americas Inc9.20110.053631130822209996244.716
2025-03-31State Street Corp3.86160.00361306535-54724-4.0201
2025-03-31Fidelity International Ltd3.62350.0784122597322561522.5534
2025-03-31Macquarie Group Ltd3.29730.0981111559612309612.4026
2025-03-31BRAIDWELL LP2.52672.0218854884-67216-7.2894
2025-03-31Hood River Capital Management LLC2.3520.91357957717957710
2025-03-31Geode Capital Management, LLC2.3450.0042793409206652.6742
2025-03-31Driehaus Capital Management LLC2.30170.5051778754179132.3544
2025-03-31Eventide Asset Management, LLC2.00390.90886779812790.0412
2025-03-31Citadel Advisors Llc1.8020.0078609689376755161.7432
2025-03-31Morgan Stanley - Brokerage Accounts1.77060.002959906014462231.8244
2024-12-31UBS Group AG1.74450.0068590242530990896.1554
2025-03-31Liontrust Investment Partners LLP1.63850.5825554357-42044-7.0496
2025-03-31Goldman Sachs Group Inc1.50.00555075108672120.6091
2025-03-31Brown Capital Management, LLC1.38360.94934681234681230
2025-03-31Emerald Advisers, LLC1.34421.37764547948308322.3515
2025-03-31Wasatch Advisors LP1.33970.1702453285119312.7033
Total 84.88597.72328720179+5881157+20.5%

4.9.2. Funds holding TransMedics Group Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-05-31iShares Core S&P Small-Cap ETF5.96160.3342201704700
2025-04-30Vanguard Total Stock Mkt Idx Inv3.02840.00551024633197971.9702
2025-05-31iShares Russell 2000 ETF2.43060.169882236400
2025-04-30Vanguard Small Cap Index2.36570.052580041056530.7113
2025-04-30Macquarie Small Cap Core I2.19281.0225741920-22361-2.9258
2025-03-31Fidelity1.90930.580364600010780020.0297
2025-04-30Fidelity Advisor New Insights I1.88540.290263790000
2025-03-31Fidelity Small Cap Growth1.85590.627662791427000.4319
2025-04-30Fidelity VIP Contrafund Initial1.81530.239661420000
2025-04-30Fidelity VIP Mid Cap Initial1.58840.742953740000
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.54560.04725229406090.1166
2025-03-31Eventide Gilead N1.36161.235246068400
2025-03-31Hood River Small-Cap Growth Instl1.31970.90394465134465130
2025-04-30Vanguard Small Cap Growth Index Inv1.31720.1228445660-1752-0.3916
2025-04-30UBS Lux AI & Rbtc Eq Fd seeding P acc1.09433.1298370246-68875-15.6847
2025-04-30Fidelity OTC1.07550.121736386800
2025-03-31Fidelity Small Cap Index0.96910.091332787818050.5536
2025-03-31Fidelity Small Cap Growth K60.8910.61230145513000.4331
2025-05-31iShares S&P Small-Cap 600 Growth ETF0.88640.64429989900
2025-04-30Fidelity World A-Dis-EUR0.88490.50492993814300.1438
Total 36.378711.477912308312+493619+4.0%

5.3. Insider Transactions

Insiders are holding 3.033% of the shares of TransMedics Group Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-06-09Anil P RanganathSELL686139.8
2025-05-27Edward M BasileSELL5000126.45
2025-05-23David WeillSELL732123.88
2025-05-09Edward M BasileSELL6000115.63
2024-12-02Tamer I KhayalSELL108486.4
2024-11-05Edward M BasileSELL675083.55
2024-10-15Waleed H HassaneinSELL8625132.71
2024-10-01Tamer I KhayalSELL2958148.24
2024-09-16Waleed H HassaneinSELL8625153.42
2024-08-27Nicholas CorcoranSELL10000176.02
2024-08-08James R TobinSELL20000159.33
2024-08-07Anil P RanganathSELL4289152.2
2024-08-06Edward M BasileSELL6750149.96
2024-08-01Tamer I KhayalSELL2958156.77
2024-07-15Waleed H HassaneinSELL8625145.17
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets837,530
Total Liabilities571,222
Total Stockholder Equity266,308
 As reported
Total Liabilities 571,222
Total Stockholder Equity+ 266,308
Total Assets = 837,530

Assets

Total Assets837,530
Total Current Assets505,918
Long-term Assets331,612
Total Current Assets
Cash And Cash Equivalents 310,143
Net Receivables 142,026
Inventory 43,380
Other Current Assets 10,369
Total Current Assets  (as reported)505,918
Total Current Assets  (calculated)505,918
+/-0
Long-term Assets
Property Plant Equipment 317,251
Goodwill 11,549
Intangible Assets 2,101
Long-term Assets Other 711
Long-term Assets  (as reported)331,612
Long-term Assets  (calculated)331,612
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities55,603
Long-term Liabilities515,619
Total Stockholder Equity266,308
Total Current Liabilities
Short-term Debt 2,791
Accounts payable 10,595
Other Current Liabilities 40,139
Total Current Liabilities  (as reported)55,603
Total Current Liabilities  (calculated)53,525
+/- 2,078
Long-term Liabilities
Long term Debt 510,098
Capital Lease Obligations Min Short Term Debt5,521
Long-term Liabilities  (as reported)515,619
Long-term Liabilities  (calculated)515,619
+/-0
Total Stockholder Equity
Common Stock709,194
Retained Earnings -442,559
Accumulated Other Comprehensive Income -327
Total Stockholder Equity (as reported)266,308
Total Stockholder Equity (calculated)266,308
+/-0
Other
Capital Stock709,194
Cash and Short Term Investments 310,143
Common Stock Shares Outstanding 39,914
Current Deferred Revenue2,078
Liabilities and Stockholders Equity 837,530
Net Debt 208,267
Net Invested Capital 776,406
Net Working Capital 450,315
Property Plant and Equipment Gross 364,142
Short Long Term Debt Total 518,410



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
0
0
0
37,001
0
51,134
48,397
42,157
38,759
121,014
112,618
105,299
96,923
163,137
159,322
152,026
145,783
140,512
131,146
134,893
124,008
117,285
274,873
277,147
287,088
690,358
689,227
706,047
723,831
758,577
785,571
804,076
837,530
837,530804,076785,571758,577723,831706,047689,227690,358287,088277,147274,873117,285124,008134,893131,146140,512145,783152,026159,322163,13796,923105,299112,618121,01438,75942,15748,39751,134037,001000
   > Total Current Assets 
47,838
0
0
34,036
24,663
47,477
43,081
34,794
30,059
116,133
107,366
100,001
91,704
158,227
154,126
146,766
140,543
135,052
125,577
118,705
105,795
95,113
250,586
252,294
261,730
662,655
536,724
510,654
488,306
509,265
492,475
497,216
505,918
505,918497,216492,475509,265488,306510,654536,724662,655261,730252,294250,58695,113105,795118,705125,577135,052140,543146,766154,126158,22791,704100,001107,366116,13330,05934,79443,08147,47724,66334,0360047,838
       Cash And Cash Equivalents 
-47,838
0
0
11,936
-24,663
34,439
28,890
20,241
12,215
47,242
20,407
20,092
24,738
51,152
21,397
24,581
26,727
25,314
22,495
25,580
17,897
30,386
204,462
201,182
195,375
582,210
427,110
394,812
350,217
362,751
330,094
336,650
310,143
310,143336,650330,094362,751350,217394,812427,110582,210195,375201,182204,46230,38617,89725,58022,49525,31426,72724,58121,39751,15224,73820,09220,40747,24212,21520,24128,89034,439-24,66311,93600-47,838
       Short-term Investments 
95,676
0
0
12,727
49,326
750
0
0
0
48,995
67,865
60,596
47,816
88,223
111,317
101,061
91,386
86,935
80,360
66,872
54,104
27,697
0
0
0
0
0
0
0
0
0
0
0
0000000000027,69754,10466,87280,36086,93591,386101,061111,31788,22347,81660,59667,86548,99500075049,32612,7270095,676
       Net Receivables 
0
0
0
925
0
2,748
3,904
3,438
5,146
7,105
6,465
6,559
6,133
4,431
6,141
6,864
7,395
6,271
4,150
5,934
11,724
12,979
22,035
27,611
38,620
47,524
60,654
63,576
81,942
81,158
90,128
97,722
142,026
142,02697,72290,12881,15881,94263,57660,65447,52438,62027,61122,03512,97911,7245,9344,1506,2717,3956,8646,1414,4316,1336,5596,4657,1055,1463,4383,9042,7480925000
       Other Current Assets 
0
0
0
477
0
535
666
3,676
2,808
3,142
4,186
3,076
3,312
3,732
4,374
4,652
3,215
3,525
7,306
5,460
10,712
13,166
11,028
2,896
3,774
2,376
9,595
8,031
7,606
16,685
20,101
16,290
10,369
10,36916,29020,10116,6857,6068,0319,5952,3763,7742,89611,02813,16610,7125,4607,3063,5253,2154,6524,3743,7323,3123,0764,1863,1422,8083,6766665350477000
   > Long-term Assets 
-47,838
0
0
2,965
-24,663
3,657
5,316
7,363
8,700
4,881
5,252
5,298
5,219
4,910
5,196
5,260
5,240
5,460
5,569
16,188
18,213
22,172
24,287
24,853
25,358
27,703
152,503
195,393
235,525
249,312
293,096
306,860
331,612
331,612306,860293,096249,312235,525195,393152,50327,70325,35824,85324,28722,17218,21316,1885,5695,4605,2405,2605,1964,9105,2195,2985,2524,8818,7007,3635,3163,657-24,6632,96500-47,838
       Property Plant Equipment 
0
0
0
2,459
0
3,151
3,342
3,474
3,750
4,375
4,746
4,792
4,713
4,404
4,690
4,754
4,734
4,954
5,063
15,688
17,713
21,672
23,787
24,353
24,100
26,894
137,865
180,487
220,647
234,926
278,682
292,451
317,251
317,251292,451278,682234,926220,647180,487137,86526,89424,10024,35323,78721,67217,71315,6885,0634,9544,7344,7544,6904,4044,7134,7924,7464,3753,7503,4743,3423,15102,459000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,673
11,990
11,990
11,549
11,549
11,549
11,549
11,54911,54911,54911,54911,99011,99011,67300000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,405
2,354
2,303
2,253
2,202
2,152
2,101
2,1012,1522,2022,2532,3032,3542,40500000000000000000000000000
       Long-term Assets Other 
-47,838
0
0
506
-24,663
506
1,974
3,889
4,950
506
506
506
506
506
506
506
506
506
6
500
500
500
500
500
508
59
560
62
85
84
663
708
711
7117086638485625605950850050050050050065065065065065065065065065064,9503,8891,974506-24,66350600-47,838
> Total Liabilities 
0
0
0
18,853
0
43,681
45,799
46,982
51,278
49,853
49,146
50,650
50,240
49,377
49,772
48,135
48,108
51,529
52,597
67,039
64,098
66,366
87,016
89,772
94,463
545,145
562,767
568,845
564,360
568,683
575,651
575,473
571,222
571,222575,473575,651568,683564,360568,845562,767545,14594,46389,77287,01666,36664,09867,03952,59751,52948,10848,13549,77249,37750,24050,65049,14649,85351,27846,98245,79943,681018,853000
   > Total Current Liabilities 
0
0
0
10,899
0
9,273
11,359
12,553
16,201
15,377
14,641
16,115
15,039
13,818
13,624
11,879
11,757
15,079
15,923
23,238
20,256
22,741
20,689
23,661
28,635
32,017
49,101
54,934
50,223
54,329
60,048
59,913
55,603
55,60359,91360,04854,32950,22354,93449,10132,01728,63523,66120,68922,74120,25623,23815,92315,07911,75711,87913,62413,81815,03916,11514,64115,37716,20112,55311,3599,273010,899000
       Short-term Debt 
0
0
0
1,805
0
0
0
0
0
0
0
0
0
0
0
0
34,787
34,921
0
8,604
2,674
2,744
2,814
1,444
2,962
3,760
3,970
4,070
2,086
4,278
5,086
2,727
2,791
2,7912,7275,0864,2782,0864,0703,9703,7602,9621,4442,8142,7442,6748,604034,92134,7870000000000001,805000
       Accounts payable 
0
0
0
3,515
0
2,742
3,689
4,720
5,499
6,662
4,766
7,247
4,860
3,722
778
1,206
1,289
2,389
2,682
6,651
2,934
5,711
3,080
3,341
4,329
7,031
12,836
12,717
9,225
13,027
13,134
10,292
10,595
10,59510,29213,13413,0279,22512,71712,8367,0314,3293,3413,0805,7112,9346,6512,6822,3891,2891,2067783,7224,8607,2474,7666,6625,4994,7203,6892,74203,515000
       Other Current Liabilities 
0
0
0
5,579
0
6,531
7,670
7,527
10,343
8,540
9,713
8,702
10,015
9,076
11,499
10,410
10,036
12,217
12,921
16,337
14,401
14,048
14,569
18,635
21,100
20,982
29,666
36,186
36,852
35,577
39,644
45,152
40,139
40,13945,15239,64435,57736,85236,18629,66620,98221,10018,63514,56914,04814,40116,33712,92112,21710,03610,41011,4999,07610,0158,7029,7138,54010,3437,5277,6706,53105,579000
   > Long-term Liabilities 
0
0
0
7,954
0
34,408
34,440
34,429
35,077
34,476
34,505
34,535
35,201
35,559
36,148
36,256
36,351
36,450
36,674
43,801
43,842
43,625
66,327
66,111
65,828
513,128
513,666
513,911
514,137
514,354
515,603
515,560
515,619
515,619515,560515,603514,354514,137513,911513,666513,12865,82866,11166,32743,62543,84243,80136,67436,45036,35136,25636,14835,55935,20134,53534,50534,47635,07734,42934,44034,40807,954000
       Long term Debt Total 
0
0
0
0
0
0
0
33,670
33,785
33,902
34,023
34,146
34,269
0
0
34,657
34,787
34,921
35,058
35,197
35,334
35,475
58,540
0
58,802
0
0
0
0
0
0
0
0
0000000058,802058,54035,47535,33435,19735,05834,92134,78734,6570034,26934,14634,02333,90233,78533,6700000000
       Other Liabilities 
0
0
0
0
0
963
876
759
667
574
482
389
932
1,164
1,623
1,599
1,564
1,529
1,616
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,6161,5291,5641,5991,6231,16493238948257466775987696300000
       Deferred Long Term Liability 
0
0
0
0
0
0
1,468
3,383
4,444
0
0
0
0
0
0
1,599
1,564
1,529
1,616
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,6161,5291,5641,5990000004,4443,3831,468000000
> Total Stockholder Equity
38,789
0
0
18,148
18,148
7,453
2,598
-4,825
-12,519
71,161
63,472
54,649
46,683
113,760
109,550
103,891
97,675
88,983
78,549
67,854
59,910
50,919
187,857
187,375
192,625
145,213
126,460
137,202
159,471
189,894
209,920
228,603
266,308
266,308228,603209,920189,894159,471137,202126,460145,213192,625187,375187,85750,91959,91067,85478,54988,98397,675103,891109,550113,76046,68354,64963,47271,161-12,519-4,8252,5987,45318,14818,1480038,789
   Common Stock
0
0
0
1
0
1
1
331,212
1
423,245
423,758
424,134
424,791
500,556
501,486
502,217
503,912
505,933
508,458
510,488
513,203
515,756
660,061
666,277
674,156
627,747
634,458
641,106
651,161
669,445
685,251
697,208
709,194
709,194697,208685,251669,445651,161641,106634,458627,747674,156666,277660,061515,756513,203510,488508,458505,933503,912502,217501,486500,556424,791424,134423,758423,2451331,2121101000
   Retained Earnings -442,559-468,241-475,098-479,314-491,508-503,705-507,736-482,314-481,313-478,677-471,957-464,531-453,008-442,446-429,778-416,816-406,148-398,231-391,920-386,832-378,335-369,483-360,306-352,026-342,831-335,936-328,301-323,1960-312,180000
   Capital Surplus 
0
0
0
0
0
0
0
143,794
143,859
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000143,859143,7940000000
   Treasury Stock000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
143,604
0
143,686
143,741
143,794
515,647
-121,014
-112,618
-2
227
36
-16
0
-89
-134
-131
68,042
-285
-306
-247
-225
-218
0
0
0
0
0
-265,411
228,967
0
0228,967-265,41100000-218-225-247-306-28568,042-131-134-890-1636227-2-112,618-121,014515,647143,794143,741143,6860143,604000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue441,540
Cost of Revenue-179,459
Gross Profit262,081262,081
 
Operating Income (+$)
Gross Profit262,081
Operating Expense-224,585
Operating Income37,49637,496
 
Operating Expense (+$)
Research Development55,968
Selling General Administrative168,617
Selling And Marketing Expenses0
Operating Expense224,585224,585
 
Net Interest Income (+$)
Interest Income0
Interest Expense-14,409
Other Finance Cost-0
Net Interest Income-14,409
 
Pretax Income (+$)
Operating Income37,496
Net Interest Income-14,409
Other Non-Operating Income Expenses0
Income Before Tax (EBT)35,78039,212
EBIT - interestExpense = 35,780
35,780
49,873
Interest Expense14,409
Earnings Before Interest and Taxes (EBIT)50,18950,189
Earnings Before Interest and Taxes (EBITDA)69,947
 
After tax Income (+$)
Income Before Tax35,780
Tax Provision-316
Net Income From Continuing Ops35,46435,464
Net Income35,464
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses404,044
Total Other Income/Expenses Net-1,71614,409
 

Technical Analysis of Transmedics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Transmedics. The general trend of Transmedics is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Transmedics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Transmedics Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Supportย is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistanceย is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of TransMedics Group Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 145.50 < 145.50 < 169.29.

The bearish price targets are: 120.30 > 98.88 > 95.90.

Know someone who trades $TMDX? Share this with them.๐Ÿ‘‡

TransMedics Group Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theย moving averageย of the selected period.

  • Moving averages are laggingย trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of TransMedics Group Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

TransMedics Group Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theย momentumย of theย selected period based on two moving averages.

  • MACD is aย lagging momentumย indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of TransMedics Group Inc. The current macd is 3.28192724.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Transmedics price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Transmedics. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Transmedics price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
TransMedics Group Inc Daily Moving Average Convergence/Divergence (MACD) ChartTransMedics Group Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of TransMedics Group Inc. The current adx is 37.39.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Transmedics shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
TransMedics Group Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Showsย the current trend.
  • Showsย potential entry signals.
  • Showsย ย potential exit signals.
  • Can be used to placeย trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of TransMedics Group Inc. The current sar is 136.72.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
TransMedics Group Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumย indicator, meaning the signals are instant.
  • Rangesย between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of TransMedics Group Inc. The current rsi is 54.84. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
TransMedics Group Inc Daily Relative Strength Index (RSI) ChartTransMedics Group Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Comparesย a certain price to multiple prices ranging over time.

  • Leadingย momentumย indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Rangesย between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of TransMedics Group Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Transmedics price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
TransMedics Group Inc Daily Stochastic Oscillator ChartTransMedics Group Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,ย the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of TransMedics Group Inc. The current cci is -21.76290631.

TransMedics Group Inc Daily Commodity Channel Index (CCI) ChartTransMedics Group Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of TransMedics Group Inc. The current cmo is 1.8056917.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
TransMedics Group Inc Daily Chande Momentum Oscillator (CMO) ChartTransMedics Group Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

ย Shows the current price relative to the highest high over the last 14 days.
ย 

  • Lagging momentum indicator
  • Ranging between 0 andย -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of TransMedics Group Inc. The current willr is -55.88703262.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Transmedics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
TransMedics Group Inc Daily Williams %R ChartTransMedics Group Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldย 

Score

Let's take a look at the Bollinger Bands of TransMedics Group Inc.

TransMedics Group Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of TransMedics Group Inc. The current atr is 5.56440331.

TransMedics Group Inc Daily Average True Range (ATR) ChartTransMedics Group Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

ย Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of TransMedics Group Inc. The current obv is -18,552,921.

TransMedics Group Inc Daily On-Balance Volume (OBV) ChartTransMedics Group Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of TransMedics Group Inc. The current mfi is 44.90.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
TransMedics Group Inc Daily Money Flow Index (MFI) ChartTransMedics Group Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for TransMedics Group Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-04-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

TransMedics Group Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of TransMedics Group Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.838
Ma 20Greater thanMa 50133.465
Ma 50Greater thanMa 100117.002
Ma 100Greater thanMa 20094.279
OpenGreater thanClose130.790
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Transmedics with someone you think should read this too:
  • Are you bullish or bearish on Transmedics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Transmedics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about TransMedics Group Inc

I send you an email if I find something interesting about TransMedics Group Inc.


Comments

How you think about this?

Leave a comment

Stay informed about TransMedics Group Inc.

Receive notifications about TransMedics Group Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.